The largest database of trusted experimental protocols

6 protocols using abbv744

1

Comprehensive Protein Analysis in Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies and sources: CDK9 (1.1000), pCDK9 (Thr187) (1.1000), RNAPII (1.1000), phospho-RNAPII(Ser2) (1.1000), PARP (1.1000), and NUP98 (1.1000) (Cell Signaling Technology); HEXIM1 (1.1000), NELF-a (1.1000), LARP-7 (1.1000), c-Myc (1.1000), SPT5 (1.1000), and GAPDH (1.5000) (Santa Cruz Biotechnology, Dallas, TX, USA); BRD4 (1.1000) (Abcam, Waltham, MA, USA); Caspase-8 (1.1000) (Enzo Life Sciences, Farmingdale, NY, USA); β-Actin (1.10000), (Sigma-Aldrich, St. Louis, MO, USA); Cyclin T (1.1000) (Bethyl, Montgomery, TX, USA). Reagents and sources: CellTiter-Blue Cell Viability assay and Caspase-Glo 3/7 assays (Promega, Madison, WI, USA); AnnexinV and 7AAD (BD); BAY1251152, BI894999, ABBV744, Paclitaxel and Carboplatin (Selleckchem, Houston, TX, USA); BioCoat Matrigel invasion chamber (Corning, Corning, NY, USA); Migration chamber (Ibidi, Gräfelfing, Germany); RNeasy Plus kit (Qiagen, Venlo, The Netherlands). The following vectors were used: pCas9(BB)-2A-Puro (PX459) V2.0 (62988, Addgene, Watertown, MA, USA); p3xFlag-CMV-7.1 (E7533, Sigma, Ronkonkoma, NY, USA).
+ Open protocol
+ Expand
2

Degradation and Inhibition of BET Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BET protein degrader dBET6 was a gift from Nathanael Gray and previously described (Winter et al., 2017 (link)). dBET6 was used at a concentration of 100 nM in all experiments except those involving the iBRD4 system, in which it was used at 10 nM. The BET bromodomain inhibitor JQ1 was a gift from James Bradner and previously described (Filippakopoulos et al., 2010 (link)). JQ1 was used at a concentration of 500 nM for all experiments. The CDK9 inhibitor DRB (Cayman Chemical Company, 10010302) was used at a concentration of 100 μM for all experiments. The TFIIH inhibitor triptolide (EMD Millipore, 645900) was used at a concentration of 250 nM (HeLa) or 1 μM (HCT-116). The topoisomerase I inhibitor, camptothecin (Selleck Chemicals), was used at a concentration of 10 μM. The topoisomerase II inhibitor, dexrazoxane (Selleck Chemicals), was used at a concentration of 50 μM. The BET bromodomain inhibitors OTX015 (Selleck Chemicals), ABBV-075 (Selleck Chemicals), ABBV-744 (Selleck Chemicals), and PLX51107 (Selleck Chemicals) where used at 2 μM, 20 nM, 50 nM, and 2 μM, respectively.
+ Open protocol
+ Expand
3

Pharmacological Screening of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds were sources from MedChem Express (unless noted) and dissolved at 10 mM in DMSO and vehicle controls used. A larger batch of INCB054329 was sourced from Selleckchem. The following compounds were used at 2 or 3 doses previously shown to have in vitro efficacy as per the referenced papers for: JQ-1 (Selleckchem), INCB054329, ABBV-744, ruxolitinib, baricitinib, flavopiridol, SEL120-34A, BI-1347, and paroxetine hydrochloride. Additional compounds tested were molibresib, alobresib, and apabetalone. For some experiments apabetalone and RVX-2157 were sent blinded by Resverogix. Compounds were given at the time of pro-inflammatory factor addition, except for experiments with baricitnib and INCB054329 where recovery of function was also assessed by addition 24 h following addition of inflammatory factors.
+ Open protocol
+ Expand
4

Multiple Myeloma Cell Lines and Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines (KMS11, OPM2, and ANBL6) were purchased from American Type Culture Collection (Manassas, VA, USA). MM.1S BzR cells were a gift from Dr. Brian Van Ness (U. of Minnesota) and have been described previously [25 (link)]. LTI6426 was provided by Leukogene Therapeutics, Inc. (Charleston, SC) with purity and identity that was confirmed by liquid chromatograph–mass spectrometry (LC–MS) and nuclear magnetic resonance (NMR) as shown previously [16 (link)]. Bortezomib (Catalog No. S1013), carfilzomib (Catalog No. S2853), panobinostat (Catalog No. S1030), vorinostat (Catalog No. S1047), ricolinostat (Catalog No. S8001), entinostat (Catalog No. S1053), romidepsin (Catalog No. S3020), tazmetostat (Catalog No. S7128), ML324 (Catalog No. S7296), JQ1 (Catalog No. S7110), OTX015 (Catalog No. S7360), ABBV744 (Catalog No. S8723), IBET151 (Catalog No. S2780), and GSK-LSD1 (Catalog No. S7574) were purchased from Selleck Chemicals (Houston, TX, USA).
+ Open protocol
+ Expand
5

Compound Screening for Viral Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compounds, JQ1 (Selleckchem, S7110), dBET6 (Selleckchem, S8762), and ABBV-744 (Selleckchem, S8732), were dissolved in DMSO as per manufacturer’s instructions. Cells were treated at the time of infection for 48 hours with media changes with fresh compound-containing media every 24 hours.
+ Open protocol
+ Expand
6

Isolation and Culture of Human Orbital Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues obtained from surgery were cut into pieces approximately 1 mm × 1 mm after removal of adipose tissues and blood vessels, and placed in T25 flasks. About 2 mL DMEM-F12 containing 20% fetal bovine serum (FBS) and 0.1% penicillin and streptomycin (both from Gibco Laboratories, Grand Island, NY, USA) was added and incubated at 37°C in a 5% CO2 humidified incubator. The media were changed every 3 days, and primary OFs were harvested after cells grew to confluence and were digested with a 0.25% trypsin solution (Gibco Laboratories). The cells were then sub-cultured in 6 cm plastic culture plates in DMEM-F12 with antibiotics and 10% FBS. OFs between the third and eighth passages were used for the subsequent experiments. Each part of the following experiment was repeated in OFs from at least three consecutive and independent specimens.
TGF-β1 (PeproTech Inc., Cranbury, NJ, USA), thiostrepton, BI6727, JQ1, and ABBV744 (all from Selleck Chemicals, Houston, TX, USA) were used for cell treatment. The solvent of thiostrepton, BI6727, JQ1, and ABBV744 was dimethylsulfoxide (DMSO; MP Biomedicals, Irvine, CA, USA). Control experiments were performed using DMSO as vehicle only without the addition of drugs.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!